Comparative evaluation of APRI, FIB-4, HFS, and NFS: Scoring tools for liver fibrosis in a Mexican population with MASLD

• Published in: Revista de Gastroenterología de México (English Edition) Vol. 89; no. 4; pp. 498 - 505
• Main Authors: Priego-Parra, B.A., Triana-Romero, A., Bernal-Reyes, R., Icaza-Chávez, M.E., Martínez-Vázquez, S.E., Amieva-Balmori, M., Cano-Contreras, A.D., Vivanco-Cid, H., Remes-Troche, J.M.
• Format: Journal Article
• Language: English
• Published: Mexico Masson Doyma México S.A 01.10.2024; Elsevier
• Subjects: Adult; Aged; Aspartate Aminotransferases - blood; Elasticity Imaging Techniques; Enfermedad hepática esteatótica asociada a disfunción metabólica; Esteatosis hepática metabólica; Fatty Liver - blood; Fatty Liver - complications; Female; Fibrosis hepática; Humans; Liver Cirrhosis - blood; Liver fibrosis; Male; MASLD; Metabolic dysfunction-associated steatotic liver; Metabolic dysfunction-associated steatotic liver disease; Mexico - epidemiology; Middle Aged; Non-alcoholic Fatty Liver Disease - blood; Non-alcoholic Fatty Liver Disease - complications; Noninvasive scores; Platelet Count; Puntajes no invasivos; Retrospective Studies; Sensitivity and Specificity; Severity of Illness Index; Mexico; Esteatosis hepática metabólica; Metabolic dysfunction-associated steatotic liver disease; Fibrosis hepática; Puntajes no invasivos; Liver fibrosis; Enfermedad hepática esteatótica asociada a disfunción metabólica; MASLD; Metabolic dysfunction-associated steatotic liver; Noninvasive scores

Liver fibrosis is a complication of metabolic dysfunction-associated steatotic liver disease (MASLD). Given the limitations and risks of liver biopsy, examining noninvasive scoring systems that are affordable for the population is necessary. Our aim was to evaluate and compare the diagnostic yield o...